Torbjørn Bjerke
Founder at Arctic Asset Management AS (Sweden)
Net worth: 523 803 $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Ulrica Slåne Bjerke | F | 59 |
Arctic Asset Management AS (Sweden)
 Arctic Asset Management AS (Sweden) Investment ManagersFinance Arctic Asset Management AS (Sweden) (AAM-Sweden) is the Sweden-based investment management arm of Arctic Asset Management AS, ultimately owned by Arctic Securities AS in Norway. The firm was founded in 2016 and is headquartered in Stockholm. AFM-Sweden manages portfolio of Nordic equities, Nordic fixed income and Global Life Science – through mutual funds and discretionary mandates for institutional clients, family offices, investment companies and private clients. | 14 years |
| Marina Bozilenko | F | 59 |
Biothea Pharma, Inc.
 Biothea Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Biothea Pharma, Inc. is an American biotechnology company that operates in the field of pharmaceuticals. The private company was founded by John F. Vavricka. Marina S. Bozilenko has been the CEO of the company since 2021. | 3 years |
| Brian Bech Nielsen | M | 66 |
University of Aarhus
| 42 years |
| Michel de Rosen | M | 73 | 6 years | |
| Timothy Morris | M | 61 | 3 years | |
| Adora Ndu | M | 43 | 3 years | |
| Pascal Wotling | M | - | 4 years | |
| Ravi Rao | M | 55 | 3 years | |
| Julie O'Neill | F | 58 | 7 years | |
| Daniel Bolanowski | M | 42 |
Arctic Asset Management AS (Sweden)
Arctic Asset Management AS (Sweden) Investment ManagersFinance Arctic Asset Management AS (Sweden) (AAM-Sweden) is the Sweden-based investment management arm of Arctic Asset Management AS, ultimately owned by Arctic Securities AS in Norway. The firm was founded in 2016 and is headquartered in Stockholm. AFM-Sweden manages portfolio of Nordic equities, Nordic fixed income and Global Life Science – through mutual funds and discretionary mandates for institutional clients, family offices, investment companies and private clients. | 8 years |
| Daniel Tassé | M | 64 | 6 years | |
| Don Soland | M | 65 | 9 years | |
| Stefan Wohlfeil | M | - |
TXP Pharma AG (Switzerland)
 TXP Pharma AG (Switzerland) Pharmaceuticals: MajorHealth Technology Part of SynAct Pharma AB, TXP Pharma AG (Switzerland) engages in researching and developing pharmaceutical drugs for the treatment of autoimmune and inflammatory diseases. The company is based in Baar, Switzerland. TXP Pharma AG (Switzerland was acquired by SynAct Pharma AB from GoodWind Holding GmbH on January 16, 2023 for $264.94 million. | - |
| Mark Fabian | M | - |
Arctic Asset Management AS (Sweden)
Arctic Asset Management AS (Sweden) Investment ManagersFinance Arctic Asset Management AS (Sweden) (AAM-Sweden) is the Sweden-based investment management arm of Arctic Asset Management AS, ultimately owned by Arctic Securities AS in Norway. The firm was founded in 2016 and is headquartered in Stockholm. AFM-Sweden manages portfolio of Nordic equities, Nordic fixed income and Global Life Science – through mutual funds and discretionary mandates for institutional clients, family offices, investment companies and private clients. | 3 years |
| Daniel Grunder | M | - |
TXP Pharma AG (Switzerland)
TXP Pharma AG (Switzerland) Pharmaceuticals: MajorHealth Technology Part of SynAct Pharma AB, TXP Pharma AG (Switzerland) engages in researching and developing pharmaceutical drugs for the treatment of autoimmune and inflammatory diseases. The company is based in Baar, Switzerland. TXP Pharma AG (Switzerland was acquired by SynAct Pharma AB from GoodWind Holding GmbH on January 16, 2023 for $264.94 million. | - |
| Rohit Mehta | M | - |
Biothea Pharma, Inc.
Biothea Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Biothea Pharma, Inc. is an American biotechnology company that operates in the field of pharmaceuticals. The private company was founded by John F. Vavricka. Marina S. Bozilenko has been the CEO of the company since 2021. | - |
| Jean-Pierre Sommadossi | M | 68 |
Biothea Pharma, Inc.
Biothea Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Biothea Pharma, Inc. is an American biotechnology company that operates in the field of pharmaceuticals. The private company was founded by John F. Vavricka. Marina S. Bozilenko has been the CEO of the company since 2021. | 9 years |
| Angela Marcucci | F | - | 4 years | |
| Michele F. Robertson | F | - | 3 years | |
| Caroline Daniere | F | 50 | 5 years | |
| Björn Westberg | M | 62 | 1 years | |
| Pharis Mohideen | M | 59 | 5 years | |
| Michael Goller | M | 49 | 9 years | |
| James Knight | M | - | 3 years | |
| Göran Tornling | M | 77 |
Biolipox AB
 Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | 18 years |
| Maïlys Ferrère | F | 60 | 8 years | |
| Thomas Boesen | M | - | 3 years | |
| Kirsten Harting | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Pierre-Henri Benhamou | M | 68 | 17 years | |
| Terje Kalland | M | 73 |
Karolinska Development AB (Private Equity)
 Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | 10 years |
| David S. Schilansky | M | 48 | 8 years | |
| Ray Hill | M | 79 | 11 years | |
| Sébastien Robitaille | M | 54 | 8 years | |
| René Schneider | M | 51 | 1 years | |
| Jørgen Drejer | M | 69 | 23 years | |
| Jeppe Øvlesen | M | 62 | 9 years | |
| Jens Bager | M | 65 | 16 years | |
| Christian Lundgren | M | 58 | 5 years | |
| Mads Peder Gersdorff Korsgaard | M | 53 | 5 years | |
| Zsolt E. Lavotha | M | - | 4 years | |
| Charlotte Elisabet Edenius | M | 66 | - | |
| George F. Horner | M | 80 | - | |
| Lars Siim Madsen | M | 53 | 9 years | |
| Bo Jesper Hansen | M | 66 |
Karolinska Development AB (Private Equity)
Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | 6 years |
| Flemming Heise Pedersen | M | 59 | 10 years | |
| Karl Lundström | M | 62 | 2 years | |
| Michael Shalmi | M | 59 | 8 years | |
| Chahra Khaoua Epouse Louafi | F | 53 | - | |
| Peter Lindborg | M | 67 | 2 years | |
| Uli Alf Hacksell | M | 74 | - | |
| Thomas Varming | M | 58 | - | |
| Christian Jepsen | M | 65 |
University of Aarhus
| 5 years |
| Charles Ruban | M | 52 | 7 years | |
| Henrik Andersen | M | 56 |
University of Aarhus
| 9 years |
| Michael Wilhelm Rosenlew | M | 65 | 2 years | |
| Christian Henrik Tange | M | 58 |
Karolinska Development AB (Private Equity)
Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | 3 years |
| Rune Fransson | M | 77 | 8 years | |
| Carsten Holt Jessen | M | 48 | - | |
| Janus Schreiber Larsen | M | 52 | - | |
| Klaus K. Wilgenbus | M | 62 | 2 years | |
| Morten Henrik Nielsen | M | 61 | 24 years | |
| Peter Hutt | M | 89 | 6 years | |
| Susanna Mesa | F | 38 | 5 years | |
| Robin Wright | M | 59 |
Karolinska Development AB (Private Equity)
Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | 6 years |
| Viviane Monges | F | 60 | 3 years | |
| Peter Sjöstrand | M | 78 | 4 years | |
| Patrik Renblad | M | 54 | 2 years | |
| Laurent Martin | M | 57 | 12 years | |
| Henrijette Richter | M | 53 | 3 years | |
| Gunilla Anders Ekström | M | 66 | - | |
| Ian Stuart Charles Talmage | M | 74 | 4 years | |
| Carl Johan Bertil Sundberg | M | 66 | 3 years | |
| Bertrand Dupont | M | 72 | 16 years | |
| Per-Olof Edin | M | 84 | 7 years | |
| Sven Anders Ullman | M | 68 | 5 years | |
| Thomas Hofman-Bang | M | 60 | 5 years | |
| Rafaèle Elisabeth Tordjman | M | 54 | 10 years | |
| Claire Giraut | F | 67 | 5 years | |
| Peter Adler Würtzen | M | 56 | - | |
| Jesper Fromberg Nielsen | M | 55 | - | |
| Jutta af Rosenborg | F | 65 | 7 years | |
| Jørgen Buus Lassen | M | 90 | 19 years | |
| Hans-Peter Torsten Ekre | M | 74 |
Karolinska Development AB (Private Equity)
Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | 9 years |
| Vladimir Valeryevich Artamonov | M | 46 | - | |
| Jim Snabe | M | 58 |
University of Aarhus
| 6 years |
| Gunnar Casserstedt | M | 74 |
Karolinska Development AB (Private Equity)
Karolinska Development AB (Private Equity) Investment ManagersFinance Karolinska Development AB (Private Equity) (Karolinska Development) is a Venture Capital firm, a subsidiary of Karolinska Development AB founded in 2003. The firm is headquartered in Solna. | 6 years |
| Henrik Frank Nielsen | M | 62 |
University of Aarhus
| 5 years |
| Etienne Adriansen | M | 60 |
University of Aarhus
| 5 years |
| Thomas Dalsgaard | M | 58 |
University of Aarhus
| 6 years |
| Palle Christophersen | M | 66 | 21 years | |
| Michael Owens | M | 68 | 5 years | |
| Henrik Dalbøge | M | 67 |
University of Aarhus
| 3 years |
| Niels Jacobsen | M | 66 |
University of Aarhus
| 1 years |
| Peter Baekgaard | M | - |
University of Aarhus
| 5 years |
| Mikael Vissing Jakobsen | M | - |
University of Aarhus
| 4 years |
| Ole Christian Anthon Christiansen | M | 67 |
University of Aarhus
| 1 years |
| Alan Jensen | M | 62 |
University of Aarhus
| 4 years |
| Henrik Nørremark | M | 58 |
University of Aarhus
| 4 years |
| Rie Schultz Hansen | M | - | 10 years | |
| Carsten Tirsbæk Madsen | M | 61 |
University of Aarhus
| 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Denmark | 35 | 35.00% |
| Sweden | 34 | 34.00% |
| France | 29 | 29.00% |
| United States | 3 | 3.00% |
| Switzerland | 2 | 2.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Torbjørn Bjerke
- Personal Network
